Bristol Myers Squibb BMY
NYSE BMY
$61.69 +2.85 (+4.85%)
As of: Oct 20, 2026 · 3:59 PM EDT

Bristol Myers Squibb (BMY) EV to EBITDA (2009 - 2026)

Updated

Bristol Myers Squibb's (BMY) EV to EBITDA was 262.65 for Q2 2026.

Analysis

Bristol Myers Squibb (BMY) EV to EBITDA (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Bristol Myers Squibb's EV to EBITDA came in at 169.88; for FY2023, it came in at 12.19, down 32.5% from FY2022.

  • By year, EV to EBITDA came in at 18.06 in FY2022 (+34.2%) and 13.46 in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly EV to EBITDA since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Bristol Myers Squibb 126.07 Bn 77.35 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 262.65
Mar 31, 2025 944.51
Dec 31, 2023 12.19
Sep 30, 2023 13.98
Jun 30, 2023 15.09
Mar 31, 2023 15.71
Dec 31, 2022 18.06
Sep 30, 2022 17.45
Jun 30, 2022 18.23
Mar 31, 2022 16.96
Dec 31, 2021 13.46
Sep 30, 2020 112.68
Sep 30, 2019 528.26
Jun 30, 2019 42.83
Mar 31, 2019 555.00
Dec 31, 2018 552.20
Sep 30, 2017 235.10
Jun 30, 2017 86.64
Mar 31, 2017 54.18
Dec 31, 2016 68.96
API Access

Bristol Myers Squibb EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BMY&period=max&api_key=YOUR_API_KEY